FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. OSRX, Inc.

    OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.

    High risk
  2. Shantou S.E.Z. Baojie Industry Co., Ltd.

    FDA warns Shantou S.E.Z. Baojie Industry over inadequate CGMP and component testing for OTC drug products, leading to Import Alert 66-40.

    High risk
  3. Tailstorm Health Inc. dba Medivant Health

    Tailstorm Health (Medivant Health) sterile compounded drugs had insanitary conditions and current good manufacturing practice failures, prompting a bevacizumab recall.

    High risk
  4. Nana Barseghian, M.D.

    FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.

    High risk
  5. Cosco International, Inc.

    FDA warned Cosco International over nonprescription drug manufacturing failures and unapproved drug products.

    High risk
  6. BEO Pharma Inc. dba BEO Pharmaceuticals Inc.

    FDA cited BEO Pharma for manufacturing quality violations, including missing identity testing of high-risk drug ingredients and releasing a batch before microbial testing.

    High risk
  7. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.

    High risk
  8. Empower Clinic Services, LLC dba Empower Pharma

    FDA warns Empower Pharma over sterile drug manufacturing deficiencies, labeling, and unapproved compounded drugs after August 2024 inspection.

    High risk
  9. Nubratori, Inc. dba Nubratori Rx

    FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.

    High risk
  10. Americo F. Padilla, M.D.

    FDA warns clinical investigator Americo F. Padilla, M.D. over failing to obtain parental consent before enrolling pediatric subjects in drug trials.

    High risk
  11. Annovex Pharma, Inc.

    FDA warns outsourcing facility Annovex Pharma in Lorton, VA, over contaminated sterile drug production and missed FDA reports.

    High risk
  12. Mehran Michael Bahrami, M.D.

    FDA warns clinical investigator Dr. Mehran Michael Bahrami over protocol violations and missing records in investigational drug trials.

    High risk
  13. Aspen Pharmacare Holdings Limited

    FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.

    High risk
  14. ProRx, LLC

    FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.

    High risk
  15. Mariscos Procesados - CAMPRESA - S.A.

    Mariscos Procesados-CAMPRESA's frozen vacuum-packed mahi-mahi fillets lacked required seafood HACCP controls, FDA says.

    High risk
  16. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  17. BioStem Life Sciences

    FDA says BioStem Life Sciences made unapproved umbilical cord and amniotic products with significant CGMP violations.

    High risk
  18. Global Calcium Pvt. Limited

    FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.

    High risk
  19. COFISA - Conservas de Peixe da Figueira, S.A.

    FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

    High risk
  20. Duong Ha Processing Trading Seafood Company Limited

    FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.

    High risk
  21. Salt City Baking Company, LLC

    FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.

    High risk
  22. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  23. Guangzhou Sinocon Food Co., Ltd

    FDA warns Guangzhou Sinocon Food over food-safety violations in ready-to-eat Oat Beta Glucan powder, including pathogen hazards and inaccurate test certificates.

    High risk
  24. Loyd Sanabria Hernandez dba Avicola Santa Fe

    FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.

    High risk
  25. Mid America Pet Food LLC

    FDA warned Mid America Pet Food after Salmonella-linked recalls and found persistent contamination and animal-food safety-rule violations at its Texas plant.

    High risk
  26. Knickerbocker 365 Inc.

    FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.

    High risk
  27. Han C. Phan, M.D.

    FDA warns clinical investigator Dr. Han C. Phan over failure to follow a drug study’s protocol for required tests.

    Medium
  28. Hangzhou Huiji Biotechnology Co., Ltd.

    FDA warned Hangzhou Huiji Biotechnology over CGMP failures in OTC hand sanitizers, including missing glycerin and ethanol safety tests.

    High risk
  29. Rise N’ Shine Farm, Inc.

    FDA warns Rise N’ Shine Farm after inspection found Salmonella Enteritidis and shell egg safety violations at its Georgia farm.

    High risk
  30. Grupo VPAS C.A.

    FDA warns Venezuela seafood processor Grupo VPAS over inadequate seafood safety plan controls for histamine and ciguatera in frozen Medregal fillets.

    High risk
  31. Maruhachi Muramatsu Inc., Danchi Factory

    FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

    High risk
  32. Kyokuyo Global Seafoods Co. LTD.

    FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.

    High risk
  33. Advance Nature Sdn Bhd

    FDA warns Malaysia's Advance Nature over inadequate heat-process controls for exported low-acid bamnut milk.

    High risk
  34. Procesadora Vikingo C.A.

    FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.

    High risk
  35. Richard W. Foltin, Ph.D.

    FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.

    High risk
  36. Golden Shrimp Seafood Joint Stock Company

    Golden Shrimp Seafood's frozen yellowfin tuna had an inadequate seafood safety plan for controlling histamine.

    High risk
  37. Rongcheng Jiayuan Food Co., Ltd

    FDA says Rongcheng Jiayuan's canned tuna is adulterated due to seafood HACCP and low-acid canned food violations.

    High risk
  38. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  39. Stokes Healthcare Inc. dba Epicur Pharma

    Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.

    High risk
  40. Bacalao Giraldo, S.L.U.

    FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.

    High risk
  41. Ya Ya Foods USA, LLC

    FDA warned Ya Ya Foods USA that its aseptic oat milk made in Ogden, Utah, was adulterated after an inspection found processing deviations.

    High risk
  42. Procesadora Marina De La Costa Oriental Del Lago C.A.

    FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.

    High risk
  43. Ice Cream House LLC

    Ice Cream House LLC's Brooklyn ice cream plant held a resident Listeria strain tied to a 2023 outbreak, FDA says.

    High risk
  44. NRS Enterprises, Inc. d/b/a Sunflour Bakery

    FDA found Sunflour Bakery's ready-to-eat baked goods made under insanitary conditions, with allergen, pest, and food-safety-plan failures.

    High risk
  45. Aerosol and Liquid Packaging, Inc.

    FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.

    High risk
  46. TJA Health, LLC

    FDA warns TJA Health LLC over unsafe drug manufacturing of toothpaste and mouth rinse due to untested components and poor quality control.

    High risk
  47. St. Louis Calco, LLC

    FDA warned St. Louis Calco, a Missouri sprout operation, that mung bean and soybean sprouts were held under insanitary conditions.

    High risk
  48. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  49. 100Misterios, LDA

    Portuguese canner 100Misterios' seafood safety plans and sardine canning process controls fall short, FDA says

    High risk
  50. Julio R. Flamini, M.D./Clinical Integrative Research Center of Atlanta

    FDA warns an Atlanta clinical investigator after a 15-year-old trial subject was given about 10 times the protocol dose.

    High risk